Ultimi tweet

Video Oncology: mechanism of action of Plitidepsin


How Plitidepsina, a marine antitumor drug developed by PharmaMar, acts on the eEF1A2 protein causing the death of tumor cells through apoptosis (programmed cell death). Plitidepsin has been designated as orphan drug by the European Medicines Agency (EMA) and the Food and Drud Administration (FDA).

Commenta questo articolo:

Il tuo indirizzo email non sarà visibile agli altri utenti.
Il commento sarà pubblicato solo previa approvazione del webmaster.